Arrowhead Pharmaceuticals, Inc. (ARWR)
77.86
-1.28
(-1.62%)
USD |
NASDAQ |
May 07, 16:00
78.30
+0.44
(+0.57%)
After-Hours: 06:25
Arrowhead Pharmaceuticals Research and Development Expense (Annual) : 585.26M for Sept. 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | 1.493B |
| Johnson & Johnson | 14.83B |
| Biogen, Inc. | 1.481B |
| Merck & Co., Inc. | 12.51B |
| Vertex Pharmaceuticals, Inc. | 3.754B |